Research
Harnessing the power of engineering and basic sciences to transform cancer research, detection, and treatment.
Education
Training future leaders in cancer research and inspiring collaboration and clinical partnerships.
Support
Providing financial support will grow our translational research impact, improving the lives of cancer patients.
The Latest News
First test of anti-cancer agent PAC-1 in human clinical trials shows promise
Illinois professor of veterinary clinical medicine Dr. Timothy Fan, left, and chemistry professor Paul Hergenrother. The U. of I. team found that the compound PAC-1 has therapeutic potential in pet dogs with spontaneously occurring cancers. The animal studies set the...
CCIL expert researchers boost activity of potential therapeutic target in triple-negative breast cancer
John Katzenellenbogen, left, Benita Katzenellenbogen and their colleagues found that stimulating estrogen receptor beta in triple-negative breast cancers alters the activity of cancer-related genes and reduces the growth and metastasis of these breast cancers. The...
A different kind of cell signal: New method enables clear, precise imaging of human cells
The interdisciplinary Beckman Institute team included (from left): Anirudha Rao, a graduate student in bioengineering; Scott Robinson, the former Beckman Institute Microscopy Suite Manager; Seth Kenkel, a postdoctoral research associate; Rohit Bhargava, director of...
Discover how Cancer Center at Illinois scientists are transforming cancer research.
Imaging.
Drug Discovery.
Tech Innovation.
Learn more about how the Cancer Center at Illinois brings scientists and physicians together to accelerate cancer care solutions.
The Oberg Family is accelerating cancer research efforts through their generous gift.
Support for the CCIL goes directly towards cancer research and education.